Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome | Zendy

Ashima Gulati | Zendy; Aditi Sinha | Zendy; Stanley C. Jordan | Zendy; Pankaj Hari | Zendy; Amit Kumar Dinda | Zendy; Sonika Sharma | Zendy; Rahul Srivastava | Zendy; Asha Moudgil | Zendy; Arvind Bagga | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic Syndrome

Author(s) -

Ashima Gulati,

Aditi Sinha,

Stanley C. Jordan,

Pankaj Hari,

Amit Kumar Dinda,

Sonika Sharma,

Rahul Srivastava,

Asha Moudgil,

Arvind Bagga

Publication year - 2010

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.03470410

Subject(s) - rituximab , medicine , nephrotic syndrome , refractory (planetary science) , complete remission , gastroenterology , surgery , chemotherapy , lymphoma , physics , astrobiology

The treatment of idiopathic nephrotic syndrome is often complicated by a refractory and relapsing course, with risk of drug toxicity and progressive renal failure. We report the efficacy and safety of rituximab in patients with steroid-resistant (SRNS) and steroid-dependent nephrotic syndrome (SDNS) refractory to standard therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research